Cantel Medical Corp. (CMD) Financial Statements (2025 and earlier)

Company Profile

Business Address OVERLOOK AT GREAT NOTCH
LITTLE FALLS, NJ 07424
State of Incorp. DE
Fiscal Year End July 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

4/30/2021
Q3
1/31/2021
Q2
10/31/2020
Q1
7/31/2020
Q4
4/30/2020
Q3
1/31/2020
Q2
10/31/2019
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments243,061258,021277,871115,76658,73049,285
Cash and cash equivalents243,061258,021277,871115,76658,73049,285
Receivables202,516185,799182,352162,980168,878174,931
Inventory, net of allowances, customer advances and progress billings170,075163,880167,960185,493184,177200,312
Inventory170,075163,880167,960185,493184,177200,312
Other undisclosed current assets22,38819,42918,44321,79025,96325,204
Total current assets:638,040627,129646,626486,029437,748449,732
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization4,2164,2224,4174,6064,6854,886
Operating lease, right-of-use asset45,81043,67944,26745,39947,32946,718
Property, plant and equipment226,132223,510225,222224,233230,023227,940
Intangible assets, net (including goodwill)1,129,0181,131,7581,140,2041,139,9511,153,3471,162,272
Goodwill665,570660,421660,172653,626656,612655,395
Intangible assets, net (excluding goodwill)463,448471,337480,032486,325496,735506,877
Deferred income tax assets  3,7384,7875,4326,9584,469
Other noncurrent assets7,0946,4676,2316,72210,80810,029
Total noncurrent assets:1,412,2701,413,3741,425,1281,426,3431,453,1501,456,314
TOTAL ASSETS:2,050,3102,040,5032,071,7541,912,3721,890,8981,906,046
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities171,986146,963135,630129,368113,324122,165
Taxes payable6,1556,7594,3736,2982,2554,939
Employee-related liabilities54,87347,78847,76932,52036,76135,727
Accounts payable54,22846,89142,00852,98637,69340,386
Accrued liabilities56,73045,52541,48037,56436,61541,113
Deferred revenue29,90828,45426,22326,88425,61426,980
Debt22,62515,1927,79141,68339,70734,252
Other undisclosed current liabilities10,0289,6029,852 25,346 
Total current liabilities:234,547200,211179,496197,935203,991183,397
Noncurrent Liabilities
Long-term debt and lease obligation830,555885,438967,513985,712928,765918,905
Long-term debt, excluding current maturities788,451845,142926,834944,011885,442875,755
Finance lease, liability4,0514,0334,1644,2284,2434,347
Liabilities, other than long-term debt69,17170,66570,60840,25634,86136,837
Deferred revenue72809297  384
Deferred income tax liabilities49,57149,53349,53327,60729,49030,923
Other liabilities19,52820,32320,77812,6495,3715,530
Operating lease, liability38,05336,26336,51537,47339,08038,803
Other undisclosed noncurrent liabilities128,371125,808124,538  34,716
Total noncurrent liabilities:1,028,0971,081,9111,162,6591,025,968963,626990,458
Total liabilities:1,262,6441,282,1221,342,1551,223,9031,167,6171,173,855
Equity
Equity, attributable to parent787,666758,381729,599688,469723,281732,191
Common stock4,6964,6934,6814,6794,7224,722
Treasury stock, value(71,182)(70,311)(68,857)(68,660)(68,494)(68,407)
Additional paid in capital281,512276,450273,040240,625265,837268,032
Accumulated other comprehensive loss(12,226)(25,249)(27,599)(42,092)(16,914)(17,020)
Retained earnings584,866572,798548,334553,917538,130544,864
Total equity:787,666758,381729,599688,469723,281732,191
TOTAL LIABILITIES AND EQUITY:2,050,3102,040,5032,071,7541,912,3721,890,8981,906,046

Income Statement (P&L) ($ in thousands)

4/30/2021
Q3
1/31/2021
Q2
10/31/2020
Q1
7/31/2020
Q4
4/30/2020
Q3
1/31/2020
Q2
10/31/2019
Q1
Revenues294,038297,029233,371236,933288,498257,246
Cost of revenue
(Cost of Goods and Services Sold)
(150,560)(149,663)(136,494)(135,950)(166,254)(141,377)
Gross profit:143,478147,36696,877100,983122,244115,869
Operating expenses(111,849)(97,014)(93,034)(78,539)(114,648)(101,445)
Operating income:31,62950,3523,84322,4447,59614,424
Interest and debt expense(15,491)(16,293)25,197(10,113)(10,250)(5,719)
Income (loss) from continuing operations before equity method investments, income taxes:16,13834,05929,04012,331(2,654)8,705
Other undisclosed loss from continuing operations before income taxes   (40,470)   
Income (loss) from continuing operations before income taxes:16,13834,059(11,430)12,331(2,654)8,705
Income tax expense (benefit)(4,070)(9,595)5,8473,456391(2,938)
Income (loss) from continuing operations:12,06824,464(5,583)15,787(2,263)5,767
Income (loss) before gain (loss) on sale of properties:12,06824,464(5,583)15,787(2,263)5,767
Net income (loss) attributable to parent:12,06824,464(5,583)15,787(2,263)5,767
Undistributed earnings (loss) allocated to participating securities, basic   2  (2)
Net income (loss) available to common stockholders, diluted:12,06824,464(5,581)15,787(2,263)5,765

Comprehensive Income ($ in thousands)

4/30/2021
Q3
1/31/2021
Q2
10/31/2020
Q1
7/31/2020
Q4
4/30/2020
Q3
1/31/2020
Q2
10/31/2019
Q1
Net income (loss):12,06824,464(5,583)15,787(2,263)5,767
Comprehensive income (loss):12,06824,464(5,583)15,787(2,263)5,767
Other undisclosed comprehensive income (loss), net of tax, attributable to parent13,0232,35014,493(25,178)1065,177
Comprehensive income (loss), net of tax, attributable to parent:25,09126,8148,910(9,391)(2,157)10,944

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: